It is a business services private limited company based in Kanpur, Uttar Pradesh, India, established in 2017.
2017 | Kanpur, Uttar Pradesh, India | ActiveKibria & Sons Pharmaceuticals Private Limited, a active private limited company, was established on 14 September 2017 in Kanpur, Uttar Pradesh, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74995UP2017PTC096975. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Sheeba Hashmi (Director), Faran Hashmi (Director), Shiban Kibria (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 117/K/13 Flat No. 809, Anand Tower, Sarvodaya Nagar,Hansnagar, Kanpur, Uttar Pradesh, 208005.
U74995UP2017PTC096975
096975
14 September 2017
₹1.00 M
₹0.50 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Kibria & Sons Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sheeba Hashmi | Director | 14 Sep 2017 | Current |
| Faran Hashmi | Director | 14 Sep 2017 | Current |
| Shiban Kibria | Director | 14 Sep 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kibria & Sons Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.81% increase. The company also saw a substantial fall in profitability, with a 10.46% decrease in profit. The company's net worth Soared by an impressive increase of 30.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Kibria & Sons Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kibria & Sons Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kibria & Sons Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kibria & Sons Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kibria & Sons Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Kibria & Sons Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was documented.
Progress on Sheeba Hashmi was appointed as a Director was appointed as a Director on 14 Sep 2017 & has been associated with this company since 8 years 2 months . was documented.
Progress on Faran Hashmi was appointed as a Director was appointed as a Director on 14 Sep 2017 & has been associated with this company since 8 years 2 months . was documented.
Progress on Shiban Kibria was appointed as a Director was appointed as a Director on 14 Sep 2017 & has been associated with this company since 8 years 2 months . was documented.
Progress on Kibria & Sons Pharmaceuticals Private Limited was registered on 14 Sep 2017 with Roc Kanpur & aged 8 years 2 months as per MCA records. was documented.
The CIN of Kibria & Sons Pharmaceuticals Private Limited is U74995UP2017PTC096975.
Kibria & Sons Pharmaceuticals Private Limited is headquartered at 117/K/13 Flat No. 809, Anand Tower, Sarvodaya Nagar,Hansnagar, Kanpur, Uttar Pradesh, 208005.
Kibria & Sons Pharmaceuticals Private Limited was incorporated on 14 September 2017.
The current directors of Kibria & Sons Pharmaceuticals Private Limited are
The primary industry of Kibria & Sons Pharmaceuticals Private Limited is Business Services.
Kibria & Sons Pharmaceuticals Private Limited is unlisted.
The authorized capital of Kibria & Sons Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Kibria & Sons Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX